US Stock MarketDetailed Quotes

LBPS 4D pharma

Watchlist
  • 1.650
  • 0.0000.00%
Close Oct 11 09:30 ET
37.19MMarket Cap-1261P/E (TTM)

4D pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
---20.45M
Other non cash items
867.95%33.04M
254.68%3.41M
-700.81%-2.21M
202.30%367.25K
---359K
Change In working capital
-269.03%-5.73M
-179.57%-1.55M
--1.95M
--0
---1.22M
-Change in receivables
-772.06%-3.56M
43.03%-408K
45.84%-716.16K
17.19%-1.32M
---1.6M
-Change in inventory
120.43%19K
---93K
----
----
---15K
-Change in prepaid assets
----
----
-94.06%128.13K
--2.16M
----
-Change in other current assets
----
----
--1.68M
--0
----
-Change in other current liabilities
----
----
261.51%1.55M
---961.46K
----
Cash from discontinued investing activities
Operating cash flow
-10.62%-25.08M
-3.64%-22.67M
7.96%-21.88M
-38.26%-23.77M
---17.19M
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
-24.54%-203K
68.62%-163K
8.59%-519.39K
69.86%-568.21K
---1.89M
Net intangibles purchase and sale
--0
73.06%-15K
-1,312.94%-55.68K
97.97%-3.94K
---194K
Net business purchase and sale
----
----
----
---699.03K
--0
Net investment purchase and sale
----
----
-66.55%9.9M
1,396.63%29.6M
--1.98M
Net other investing changes
----
----
--41.95K
----
----
Cash from discontinued investing activities
Investing cash flow
-14.04%-203K
-101.90%-178K
-66.94%9.37M
6,844.18%28.33M
--408K
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt
--8.99M
--0
--0
----
----
Net common stock issuance
-6.17%27.9M
--29.74M
--0
--0
----
Net other financing activities
-80.00%1K
--5K
----
----
----
Cash from discontinued financing activities
Financing cash flow
15.17%32.01M
260,366.43%27.79M
-4.22%-10.68K
26.82%-10.25K
---14K
Net cash flow
Beginning cash position
128.75%8.78M
-75.40%3.84M
23.27%15.59M
-55.87%12.65M
--28.66M
Current changes in cash
36.10%6.72M
139.45%4.94M
-374.83%-12.52M
127.12%4.56M
---16.8M
Effect of exchange rate changes
----
----
169.82%762.68K
---1.09M
----
End cash Position
76.60%15.5M
128.69%8.78M
-76.19%3.84M
35.80%16.11M
--11.87M
Free cash flow
-10.65%-25.29M
-1.78%-22.85M
7.76%-22.45M
-26.31%-24.34M
---19.27M
Currency Unit
GBP
GBP
GBP
GBP
GBP
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M---20.45M
Other non cash items 867.95%33.04M254.68%3.41M-700.81%-2.21M202.30%367.25K---359K
Change In working capital -269.03%-5.73M-179.57%-1.55M--1.95M--0---1.22M
-Change in receivables -772.06%-3.56M43.03%-408K45.84%-716.16K17.19%-1.32M---1.6M
-Change in inventory 120.43%19K---93K-----------15K
-Change in prepaid assets ---------94.06%128.13K--2.16M----
-Change in other current assets ----------1.68M--0----
-Change in other current liabilities --------261.51%1.55M---961.46K----
Cash from discontinued investing activities
Operating cash flow -10.62%-25.08M-3.64%-22.67M7.96%-21.88M-38.26%-23.77M---17.19M
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale -24.54%-203K68.62%-163K8.59%-519.39K69.86%-568.21K---1.89M
Net intangibles purchase and sale --073.06%-15K-1,312.94%-55.68K97.97%-3.94K---194K
Net business purchase and sale ---------------699.03K--0
Net investment purchase and sale ---------66.55%9.9M1,396.63%29.6M--1.98M
Net other investing changes ----------41.95K--------
Cash from discontinued investing activities
Investing cash flow -14.04%-203K-101.90%-178K-66.94%9.37M6,844.18%28.33M--408K
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt --8.99M--0--0--------
Net common stock issuance -6.17%27.9M--29.74M--0--0----
Net other financing activities -80.00%1K--5K------------
Cash from discontinued financing activities
Financing cash flow 15.17%32.01M260,366.43%27.79M-4.22%-10.68K26.82%-10.25K---14K
Net cash flow
Beginning cash position 128.75%8.78M-75.40%3.84M23.27%15.59M-55.87%12.65M--28.66M
Current changes in cash 36.10%6.72M139.45%4.94M-374.83%-12.52M127.12%4.56M---16.8M
Effect of exchange rate changes --------169.82%762.68K---1.09M----
End cash Position 76.60%15.5M128.69%8.78M-76.19%3.84M35.80%16.11M--11.87M
Free cash flow -10.65%-25.29M-1.78%-22.85M7.76%-22.45M-26.31%-24.34M---19.27M
Currency Unit GBPGBPGBPGBPGBP
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg